Home
About Us
Investors
Back
Stock Info
Capital Structure
Media
Corporate Presentation
Financial Statements
Investments
Back
Mindbio Therapeutics
Digital Mind Technologies
TERP Wholesale LLC
Trip Pharma
Sac Pharma
Spaced Food
Noble Hemp
Medigen + TBG
News
Back
2024
2023
2022
2021
2020
Contact
NEWS RELEASES
CSE:
BLR
| Frankfurt:
0JJ
| US-OTC:
BLRZF
2024
2023
2022
2021
2020
Articles
Title
Created Date
Blackhawk Growth's Spaced Food To Launch In Canada's Largest Market
Dec 19
Blackhawk Growth Receives Court Approval to Hold Special Meeting on December 22nd 2022 to Approve Mindbio Therapeutics Spinout
Dec 02
Blackhawk Growth Announces Shareholder Meeting for December 22, 2022 to Vote on the Spin-Out of Mindbio Therapeutics
Nov 07
Blackhawk's Mindbio Reveals Positive Data From Phase 1 Randomised Double-Blind Placebo Controlled Clinical Trials Microdosing LSD In 80 Healthy Participants
Nov 04
Blackhawk Growth to Reprofile Existing Credit Facility and Add Additional $2 Million Dollar Facility
Oct 28
BLACKHAWK's Mindbio Announces Phase 2A/B Clinical Trials Microdosing LSD in Major Depressive Disorder Submitted for Ethics & Regulatory Approval
Sep 28
BLACKHAWK's Mindbio Nominated for Company of the Year by Industry Peers as it Prepares for Phase 2 Clinical Trials
Sep 22
Blackhawk's MindBio Therapeutics Announces Reveal Date for Presentation of Phase 1 Clinical Trial Data
Sep 15
Blackhawk Growth's Spaced Food Manufacturing Partner Completes Development of Spaced Food Edibles; Prepares for Commercial Production
Aug 29
Blackhawk Growth Sets AGM Date and Provides Corporate Update
Aug 09
Blackhawk's Mindbio Therapeutics Announces Research Collaborators at University of Auckland Receive Grant Funding of $1.44 Million for LSD Microdosing Trials in Major Depressive Disorder
Jul 25
Blackhawk's Terp Wholesale LLC Reports Unaudited Cdn$1,644,043 in Gross Revenue for First Five Months Ended May 31st, 2022
Jun 16
Blackhawk Appoints Justin Hanka as Chairman of The Board
Jun 06
Blackhawk Growth Files Quarter Ended March 31, 2022 Financials and Reports Increase in Value of its Portfolio by 8.8% Quarter Over Quarter
May 30
Blackhawk's Terp Wholesale LLC Expands Facility, Launches Retail Delivery
May 24
Blackhawk's Mindbio Therapeutics Accelerates Global Communications Expansion Ahead of Phase 2 Clinical Trials
May 11
Blackhawk's MindBio Therapeutics Announces Completion of World First Phase 1 Microdosing Clinical Trial
May 03
Blackhawk Growth Closes Investment in Blum Distributors
Apr 28
BLACKHAWK GROWTHS Blum Distributors Expands Facility and Starts to Fulfill Applied Myco Order
Apr 19
BLACKHAWK GROWTH to Acquire Mycology Supplier and Cultivator - Blum Distributors
Apr 06
Blackhawk's MindBio Therapeutics Enters its 80th and Final Patient into Phase 1 Clinical Trials and Provides Update for MindBio Spinout
Apr 04
Blackhawk Growth's Spaced Food Adds New Flavours and Signs Partnership Agreement with Gaia Grow's Canadian Cannabis Laboratory Tru Extracts for Manufacturing of Blackhawk's Spaced Food Products
Mar 31
Blackhawks Mindbio Therapeutics Announces Investment in Health Research Platform Quantified Citizen, a Health Technology Company Disrupting and Decentralizing Clinical Research
Mar 15
Blackhawk Growth Closes Investment in Stable Foods
Mar 11
Blackhawk's MindBio Therapeutics Invests NZ$2.3 Million to Fast Track Psychedelic Microdosing Phase 2 Clinical Trials
Mar 10
Blackhawk's MindBio Therapeutics Announces Platinum Sponsorship of Plant Medicine Week in Malta
Mar 08
Blackhawk Growth to Acquire Remaining 49% of NuWave Foods; NuWave Foods Changes Name to Stable Foods
Feb 28
Blackhawk Subsidiary Digital Mind Technology Starts Phase 1 Development of Digital Therapeutic Platform and is on Track for Completion in Q2, 2022
Feb 17
Blackhawk Publishes MindBio Therapeutics Investor Presentation & Q&A Event on Website
Feb 03
Blackhawk CEO Frederick Pels and MindBio Therapeutics Co-Founder Justin Hanka Will Lead Investor Presentation and Q&A Session Wednesday, February 2nd at 3pm Pacific Standard Time
Feb 01
Blackhawk Launches New Website, Corporate Presentation and Engages Investor Relations Professional to Expand Outreach
Jan 26
Blackhawk's MindBio Therapeutics Ahead of Schedule to Complete Phase 1 Clinical Trial Microdosing of Psychedelic Medicines and Provides Updates on Spinout Process
Jan 24
Blackhawk's MindBio Therapeutics to Develop Psychedelic Medicine in Microdoses Ready for Commercial Use to Treat Major Depressive Disorder
Jan 17
Blackhawk’s TERP Wholesale LLC Receives State-Issued Micro-Business License Allowing for Retail Delivery
Jan 12
Blackhawk’s TERP Wholesale LLC Reports Unaudited $2,503,133 in Gross Revenue for Nine Months Ended September 30th, 2021
Jan 06
Blackhawk’s MindBio Therapeutics to Develop Proprietary Drug Delivery Technology for Psychedelic Medicines
Jan 04